DK2102655T3 - In vitro-fremgangsmåde til diagnosticering af prostatacancer - Google Patents

In vitro-fremgangsmåde til diagnosticering af prostatacancer

Info

Publication number
DK2102655T3
DK2102655T3 DK08701192.0T DK08701192T DK2102655T3 DK 2102655 T3 DK2102655 T3 DK 2102655T3 DK 08701192 T DK08701192 T DK 08701192T DK 2102655 T3 DK2102655 T3 DK 2102655T3
Authority
DK
Denmark
Prior art keywords
prostatances
diagnosticing
vitro procedure
vitro
procedure
Prior art date
Application number
DK08701192.0T
Other languages
English (en)
Inventor
Claude Cochet
Odile Filhol
Mathieu Laramas
Original Assignee
Inst Nat Sante Rech Med
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Commissariat Energie Atomique filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK2102655T3 publication Critical patent/DK2102655T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK08701192.0T 2007-01-10 2008-01-02 In vitro-fremgangsmåde til diagnosticering af prostatacancer DK2102655T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07290032A EP1944609A1 (en) 2007-01-10 2007-01-10 In vitro method for diagnosing prostate cancer
PCT/EP2008/050004 WO2008083998A1 (en) 2007-01-10 2008-01-02 In vitro method for diagnosing prostate cancer

Publications (1)

Publication Number Publication Date
DK2102655T3 true DK2102655T3 (da) 2014-01-06

Family

ID=38068437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08701192.0T DK2102655T3 (da) 2007-01-10 2008-01-02 In vitro-fremgangsmåde til diagnosticering af prostatacancer

Country Status (5)

Country Link
US (1) US8829162B2 (da)
EP (2) EP1944609A1 (da)
CA (1) CA2674739C (da)
DK (1) DK2102655T3 (da)
WO (1) WO2008083998A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3112477A1 (en) * 2008-02-28 2017-01-04 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of prostate related disorders
EP2472263A1 (en) 2011-01-03 2012-07-04 Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives Methods for the prognostic assessment of breast cancer
WO2021132544A1 (ja) * 2019-12-25 2021-07-01 公立大学法人福島県立医科大学 癌の予後バイオマーカー

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288110B2 (en) * 2006-12-04 2012-10-16 Perkinelmer Health Sciences, Inc. Biomarkers for detecting cancer

Also Published As

Publication number Publication date
CA2674739A1 (en) 2008-07-17
EP2102655A1 (en) 2009-09-23
CA2674739C (en) 2017-05-09
EP1944609A1 (en) 2008-07-16
US8829162B2 (en) 2014-09-09
WO2008083998A1 (en) 2008-07-17
US20100136576A1 (en) 2010-06-03
EP2102655B1 (en) 2013-11-06

Similar Documents

Publication Publication Date Title
LU92600I2 (fr) Sovaldi (sofosbuvir)
DK2068927T3 (da) Fremgangsmåder til reducering af eosinofilniveauer
DE102007063274B8 (de) Mikroskop
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
BRPI0821573A2 (pt) benzofuropirimidonas
ATE501136T1 (de) Imidazopyridinone
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
BRPI0811451A2 (pt) Exopolissacarídeo
BRPI0814519A2 (pt) Organopolissiloxano
BRPI0812840A2 (pt) 2-imidazolinas
ITMI20060591A1 (it) Innesto rapido
AT505058A3 (de) Türschliesssystem
BRPI0815547A2 (pt) Depsipeptídeos cícliocos
BRPI0809678A2 (pt) Métodos
BRPI0812994A2 (pt) Microbiocidas
NO2022038I1 (no) ropeginterferon alfa-2b
DE112008001216A5 (de) Magnetronplasmaanlage
DE502008001751D1 (de) Korrektor
DK2262525T3 (da) Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme
DE112008003094A5 (de) Geomatte
ATE506032T1 (de) Endoprothesenkomponente
DE112008002200A5 (de) Sperrsynchronisiervorrichtung
CU20090155A7 (es) Macrolidos
DK2203410T3 (da) Fremgangsmåde til fremstilling af 4-aminobut-2-enolider
DK2102655T3 (da) In vitro-fremgangsmåde til diagnosticering af prostatacancer